State of Michigan Retirement System Sells 400 Shares of Agilent Technologies, Inc. (NYSE:A)

State of Michigan Retirement System cut its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 82,981 shares of the medical research company’s stock after selling 400 shares during the quarter. State of Michigan Retirement System’s holdings in Agilent Technologies were worth $11,537,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of A. Synovus Financial Corp boosted its position in shares of Agilent Technologies by 2.3% during the first quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company’s stock worth $895,000 after purchasing an additional 153 shares in the last quarter. Blair William & Co. IL boosted its position in shares of Agilent Technologies by 7.3% during the first quarter. Blair William & Co. IL now owns 28,606 shares of the medical research company’s stock worth $3,785,000 after purchasing an additional 1,957 shares in the last quarter. Sequoia Financial Advisors LLC boosted its position in shares of Agilent Technologies by 52.1% during the first quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock worth $309,000 after purchasing an additional 799 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Agilent Technologies by 1.1% during the first quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock worth $3,246,209,000 after purchasing an additional 261,435 shares in the last quarter. Finally, Zions Bancorporation N.A. boosted its position in shares of Agilent Technologies by 10.8% during the first quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company’s stock worth $381,000 after purchasing an additional 281 shares in the last quarter. 87.42% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. TheStreet raised shares of Agilent Technologies from a “c+” rating to a “b-” rating in a research report on Friday, December 8th. Citigroup boosted their price objective on shares of Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. UBS Group lifted their price target on shares of Agilent Technologies from $130.00 to $155.00 and gave the company a “neutral” rating in a research note on Wednesday, February 28th. Wolfe Research started coverage on shares of Agilent Technologies in a research note on Wednesday, December 13th. They issued an “outperform” rating and a $140.00 price target on the stock. Finally, JPMorgan Chase & Co. lifted their price target on shares of Agilent Technologies from $140.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, December 20th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $138.29.

Get Our Latest Report on Agilent Technologies

Agilent Technologies Stock Down 1.0 %

Shares of A opened at $144.17 on Wednesday. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $151.58. The firm has a market cap of $42.25 billion, a P/E ratio of 34.33, a price-to-earnings-growth ratio of 4.40 and a beta of 1.11. The firm’s 50-day simple moving average is $138.83 and its 200 day simple moving average is $127.05. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Tuesday, February 27th. The medical research company reported $1.29 EPS for the quarter, topping the consensus estimate of $1.22 by $0.07. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the company earned $1.37 EPS. The firm’s revenue was down 5.5% compared to the same quarter last year. On average, analysts forecast that Agilent Technologies, Inc. will post 5.51 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd will be paid a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Monday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.38%.

Insider Buying and Selling at Agilent Technologies

In other news, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the sale, the director now directly owns 54,976 shares in the company, valued at approximately $7,935,235.84. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the sale, the director now directly owns 54,976 shares in the company, valued at approximately $7,935,235.84. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Michael R. Mcmullen sold 52,297 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the transaction, the chief executive officer now directly owns 253,909 shares of the company’s stock, valued at $38,086,350. The disclosure for this sale can be found here. Insiders have sold 61,610 shares of company stock worth $9,220,333 over the last ninety days. Insiders own 0.33% of the company’s stock.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Articles

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.